Choksi Laboratories

quarterly
yearly
ParticularsJun '23Sep '23Dec '23Mar '24Jun '24
Revenue8.888.008.7911.1810.75
Expenses8.667.998.659.9010.13
EBITDA2.432.162.253.552.83
EBIT1.040.750.822.061.34
Profit Before Tax0.220.010.141.280.61
Net Profit0.360.010.060.680.42
Financial Ratios
Operating Profit Margin27.52%27.17%25.60%31.92%26.44%
Net Profit Margin4.08%0.13%0.68%6.12%3.91%
Earning Per Share (Diluted)0.510.010.090.980.60
Dividends Per Share0.000.000.000.000.00
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 5.4.4
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ